ABEONA THERAPEUTICS INC. Defined Contribution Plan, Cost
ABEONA THERAPEUTICS INC. (ABEO) reported Defined Contribution Plan, Cost of $1.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-03-17
- ABEONA THERAPEUTICS INC. defined contribution plan, cost for fiscal 2025 was $1.00M, a 100.00% increase from fiscal 2024.
- ABEONA THERAPEUTICS INC. defined contribution plan, cost for fiscal 2024 was $500.00K, a 66.67% increase from fiscal 2023.
- ABEONA THERAPEUTICS INC. defined contribution plan, cost for fiscal 2023 was $300.00K, a 0.00% change from fiscal 2022.
- ABEONA THERAPEUTICS INC. defined contribution plan, cost for fiscal 2022 was $300.00K, a 25.00% decline from fiscal 2021.
| Period end | Defined Contribution Plan, Cost 12 month | Defined Contribution Plan, Cost 12 month as first filed |
|---|---|---|
| 2025-12-31 | $1.00M 10-K · filed 2026-03-17 | |
| 2024-12-31 | $500.00K 10-K · filed 2026-03-17 | |
| 2023-12-31 | $300.00K 10-K · filed 2025-03-20 | |
| 2022-12-31 | $300.00K 10-K · filed 2024-03-18 | |
| 2021-12-31 | $400.00K 10-K · filed 2023-03-29 | |
| 2020-12-31 | $300.00K 10-K · filed 2022-03-31 | |
| 2019-12-31 | $400.00K 10-K · filed 2021-03-24 | |
| 2018-12-31 | $300.00K 10-K · filed 2020-03-16 | $317.00K 10-K · filed 2019-03-18 |
| 2017-12-31 | $0.00 10-K · filed 2020-03-16 | |
| 2016-12-31 | $0.00 10-K · filed 2019-03-18 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-30 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-31 | |
| 2012-12-31 | $0.00 10-K · filed 2014-03-26 | |
| 2011-12-31 | $40.00K 10-K · filed 2013-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |